Table 4.
Parameter | All trials | Duration ≤13 wk | Duration >13 wk | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Coefficient | P | R2 | No. of studies | Coefficient | P | R2 | No. of studies | Coefficient | P | R2 | |
Blood glucose | 12 | 0.27 | .39 | 0.08 | 7 | −1.60 | .06 | 0.54 | 5 | 0.73 | .43 | 0.22 |
Insulin | 7 | −0.55 | .37 | 0.16 | 4 | −0.60 | .87 | 0.02 | 3 | −0.19 | .56 | 0.41 |
HOMA-IR | 5 | −0.03 | .80 | 0.03 | 4 | −0.21 | .40 | 0.36 | 1 | NA | NA | NA |
Total cholesterol | 10 | 0.21 | .84 | 0.01 | 6 | −0.9 | .64 | 0.06 | 4 | 6.58 | .32 | 0.46 |
Triglycerides | 10 | −0.78 | .65 | 0.03 | 6 | −4.51 | .39 | 0.19 | 4 | −4.54 | .71 | 0.08 |
LDL cholesterol | 7 | 0.98 | .16 | 0.35 | 4 | 1.56 | .12 | 0.78 | 3 | 5.57 | .23 | 0.88 |
HDL cholesterol | 10 | −0.95 | .01 | 0.60 | 6 | −2.03 | .11 | 0.52 | 4 | 0.29 | .75 | 0.06 |
Abbreviations: HDL, high-density lipoprotein; HOMA-IR, Homeostatic Model Assessment for Insulin Resistance; LDL, low-density lipoprotein; NA, not applicable.